| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/10/2026 | ±8.1% | -3.4% | over-priced |
| 05/07/2026 | ±7.1% | -7.2% | under-priced |
| 11/10/2025 | ±9.3% | +0.5% | over-priced |
| 08/07/2025 | ±5.2% | +0.3% | over-priced |
| 05/08/2025 | ±3.9% | +3.6% | over-priced |
| 11/12/2024 | ±7.3% | -0.8% | over-priced |
| 08/08/2024 | ±7.8% | +4.2% | over-priced |
| 05/06/2024 | ±3.8% | +1.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $-0.08 | $234M | $-49M |
| Q1 FY2026 | $-0.07 | $200M | $-45M |
| Q4 FY2025 | $-0.09 | $180M | $-53M |
| Q3 FY2025 | $-0.03 | $155M | $-18M |
Rocket Lab Corporation Common Stock (RKLB) reports in 81 days, with the next report estimated for 12/02/2026. Across the last 8 reports, options priced an average ±6.6% earnings move while the stock actually moved 2.7% on average — the market has systematically over-priced RKLB's earnings risk. Fundamentals into the print: EPS up 38.5% year-over-year, revenue up 62.0%. QuantLogix's live 5-factor engine currently reads RKLB as a underweight at 20/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →